Marsh & McLennan Companies, Inc. $MRSH Shares Sold by Banque Pictet & Cie SA

Key Points

• Banque Pictet & Cie SA reduced its Marsh McLennan stake by 24% in the third quarter, selling 30,421 shares and retaining 96,433 shares worth approximately $16.5 million. Institutional investors collectively own nearly 88% of the company.
• Marsh McLennan exceeded third-quarter expectations, reporting adjusted EPS of $2.03 versus the $1.96 consensus and revenue of $6.86 billion, up 8.1% year over year.
• Analysts remain broadly cautious despite raising some price targets. The stock has a consensus “Hold” rating with a $203.60 target, while higher operating costs and challenging conditions remain potential risks; the company also declared a quarterly dividend of $0.99 per share.

Banque Pictet & Cie SA cut its holdings in Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) by 24.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 96,433 shares of the financial services provider's stock after selling 30,421 shares during the quarter. Banque Pictet & Cie SA's holdings in Marsh & McLennan Companies were worth $16,464,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of MRSH. Focus Partners Advisor Solutions LLC bought a new stake in Marsh & McLennan Companies during the 2nd quarter worth about $2,153,000. Daiichi Life Insurance Co. Ltd. acquired a new position in shares of Marsh & McLennan Companies during the 2nd quarter worth approximately $3,880,000. Korea Investment CORP acquired a new position in shares of Marsh & McLennan Companies during the 2nd quarter worth approximately $46,856,000. Bank of Nova Scotia bought a new stake in shares of Marsh & McLennan Companies during the 2nd quarter worth approximately $20,681,000. Finally, Essex LLC bought a new position in shares of Marsh & McLennan Companies in the first quarter valued at $2,891,000. Institutional investors and hedge funds own 87.99% of the company's stock.

Key Headlines Impacting Marsh & McLennan Companies

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Q3 earnings and revenue exceeded expectations. Marsh reported adjusted EPS of $2.03, above the $1.96 consensus, while revenue reached $6.86 billion, an 8.1% year-over-year increase. Growth in Consulting and Risk and Insurance Services helped offset higher operating expenses. Marsh Reports Third Quarter 2026 Results
• Positive Sentiment: Management highlighted continued growth and execution. CEO John Doyle cited 5% underlying revenue growth, double-digit EPS growth, progress on the Thrive program and completion of the company’s brand transition. The earnings call also emphasized artificial intelligence initiatives and a new resilience coalition focused on rising global business risks. Marsh & McLennan Earnings Call Highlights Growth, AI Focus
• Positive Sentiment: Analysts raised their valuation targets. Citigroup increased its target from $200 to $203, while Wells Fargo raised its target from $183 to $197. Both firms retained neutral or equal-weight ratings, suggesting improved expectations but limited conviction for significant outperformance.
• Neutral Sentiment: Analyst opinion remains cautious. RBC Capital maintained its hold rating, and the latest targets remain close to the stock’s recent trading range. This indicates that the earnings beat has improved estimates without substantially changing the broader valuation debate. RBC Capital Maintains Hold Rating
• Negative Sentiment: Challenging operating conditions and higher costs remain risks. Commentary indicates that the difficult operating environment may persist, while rising expenses could pressure margins and reduce the benefit of revenue growth. Challenging Operating Environment Likely to Persist

Marsh & McLennan Companies Trading Up 1.1%

NYSE MRSH opened at $188.65 on Friday. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.09 and a quick ratio of 1.14. The company has a fifty day moving average of $181.17. Marsh & McLennan Companies, Inc. has a 12 month low of $156.60 and a 12 month high of $198.49. The stock has a market cap of $90.03 billion, a price-to-earnings ratio of 17.94, a P/E/G ratio of 2.59 and a beta of 0.59.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its earnings results on Thursday, October 15th. The financial services provider reported $2.03 earnings per share for the quarter, topping analysts' consensus estimates of $1.96 by $0.07. The firm had revenue of $6.86 billion for the quarter. Marsh & McLennan Companies had a return on equity of 33.32% and a net margin of 14.20%. The business's revenue was up 8.1% on a year-over-year basis. As a group, sell-side analysts predict that Marsh & McLennan Companies, Inc. will post 10.44 EPS for the current fiscal year.

Marsh & McLennan Companies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Thursday, October 1st will be paid a $0.99 dividend. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $3.96 annualized dividend and a yield of 2.1%. Marsh & McLennan Companies's payout ratio is currently 48.41%.

Analyst Upgrades and Downgrades

MRSH has been the subject of several research reports. Wells Fargo & Company raised their price objective on shares of Marsh & McLennan Companies from $183.00 to $197.00 and gave the stock an "equal weight" rating in a research report on Friday. JPMorgan Chase & Co. upped their target price on Marsh & McLennan Companies from $212.00 to $215.00 and gave the company an "overweight" rating in a research report on Thursday, October 1st. Cantor Fitzgerald increased their target price on Marsh & McLennan Companies from $212.00 to $218.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 21st. Bank of America reduced their price target on Marsh & McLennan Companies from $179.00 to $178.00 and set an "underperform" rating for the company in a research note on Wednesday, July 15th. Finally, The Goldman Sachs Group decreased their price objective on Marsh & McLennan Companies from $197.00 to $191.00 and set a "neutral" rating on the stock in a report on Thursday, October 1st. Two equities research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, twelve have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $203.60.

Insiders Place Their Bets

In related news, insider Martin South sold 7,100 shares of the stock in a transaction dated Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total transaction of $1,348,929.00. Following the completion of the sale, the insider directly owned 16,632 shares in the company, valued at $3,159,913.68. This represents a 29.92% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Lloyd Yates sold 12,000 shares of the firm's stock in a transaction that occurred on Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total value of $2,107,800.00. Following the transaction, the director owned 12,001 shares in the company, valued at approximately $2,107,975.65. The trade was a 50.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 19,813 shares of company stock valued at $3,597,903 over the last three months. Insiders own 0.38% of the company's stock.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies, now operating under the name Marsh McLennan, is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through four principal businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman.

Marsh is an insurance brokerage and risk adviser that helps clients identify, manage and transfer risk. Guy Carpenter provides reinsurance brokerage and advisory services to insurance companies.

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.